Posted by Michael Wonder on 01 Jun 2023
Pharmaceutical industry ought to justify drug prices on value, not R&D costs
1 June 2023 - Drug companies will often claim they need to charge high prices to recover their research and development (R&D) costs.
While this certainly is the case for drugs targeting (ultra) rare diseases, in an optimally functioning pharmaceutical market most prices ought to reflect value, not R&D costs.
